AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
What Does Index Level Tell You About The Market explains how the index reflects market conditions and helps you interpret momentum for decisions.
28,521 articlesAbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
GE Vernova’s stock slid after a mixed Q2 report, with earnings missing estimates but revenue beating forecasts. This ...
Chemours faces a year of nuanced cycles in pigments and fluorochemicals. This guide breaks down what to watch in chem...
Capital moves matter. Capricorn Investment Group reduced its Navitas Semiconductor stake by about 1.19 million shares...
As Guidewire charts its path through cloud adoption and insurer modernization, guidewire (gwre) 2026 earnings become ...
Hims Hers Health shares jumped after news of a Novo Nordisk collaboration. This guide breaks down what the deal could...
MP Materials is catching attention from large buyers of stock as it moves to boost magnet production and solidify the...
Investors are buzzing about Revolution Medicines this year as its RAS-focused cancer programs advance. This article l...
This guide dives into Arbe's Q2 2025 earnings, decoding revenue growth, margins, and guidance. Learn actionable ways ...
When energy costs rise, investors often look for EV players that could benefit. This article unpack Rivian's path to ...
A major gaming operator dominates the spotlight with $11.5 billion in revenue, while a $16 million institutional exit...
Bastion Asset Management just revealed a new stake in Parsons, signaling confidence in steady government spending on ...